Quick Takeaways: Why It Matters? Wonderdog’s membership-based at-home diagnostics and AI monitoring platform shifts canine care from episodic, symptom-driven visits to continuous, data-driven prevention, creating a new revenue model tied to recurring testing, subscriptions, and personalize...
Quick Takeaways: Why It Matters? Full FDA approval for Laverdia transforms it from a conditionally approved option into the first fully approved oral, at‑home standard therapy for canine lymphoma, which should significantly boost veterinarian confidence and utilization via Dechra’s nationa...
The US FDA’s 2025 animal health approvals highlight a transformative year for veterinary medicine, with major advances spanning companion animal therapeutics, livestock productivity, poultry health, parasitic disease management, diagnostics, oncology, and genetic innovation. The latest wav...
Quick Takeaways: Why It Matters? Unlike drugs that carry safety concerns or diminishing effectiveness, LIFU aims to provide a non-invasive alternative to nerve blocks and radiofrequency ablation without systemic exposure, which could reduce reliance on medications and invasive procedures. ...
Quick Takeaways: Why It Matters? This deal gives Merck Animal Health an early, exclusive window into a gene-therapy pipeline for chronic and age-related diseases in pets, while Rejuvenate Bio secures non-dilutive R&D support and a $6M financing round to advance its platform...
Quick Takeaways: Why It Matters? Waltham Petcare is moving canine dentistry from “late detection” to early prediction by rolling out an explainable AI risk model that uses a hybrid causal Bayesian network to flag dogs at high risk of periodontal disease befo...
Quick Takeaways: Why It Matters? MiDOG’s expanded WGS panel positions it as a high-end reference option for difficult, polymicrobial, or refractory cases, where traditional culture and targeted PCR often fall short. By consolidating bacteria, fungi...
